コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 simulations of Carbamazepine in treatment of Trigeminal Neuralgia.
2 dromes have shown striking similarities with trigeminal neuralgia.
3 ader nosological concept of SUNCT, SUNA, and trigeminal neuralgia.
4 hophysiological basis between SUNCT/SUNA and trigeminal neuralgia.
5 the adverse events such as xerophthalmia and trigeminal neuralgia.
6 nces the pathophysiology of pre- and typical trigeminal neuralgia.
7 n be depicted noninvasively in patients with trigeminal neuralgia.
8 r or visual complaints following surgery for trigeminal neuralgia.
9 d complications of the surgical treatment of trigeminal neuralgia.
10 ty can result from the surgical treatment of trigeminal neuralgia.
11 nstrated in multiple sclerosis patients with trigeminal neuralgia.
12 e trigeminal nerve for medically intractable trigeminal neuralgia.
13 that may underlie pain in this kindred with trigeminal neuralgia.
14 arteriovenous malformations (1089 [22.2%]), trigeminal neuralgia (565 [11.5%]), pituitary adenomas (
15 that cerebrospinal fluid from patients with trigeminal neuralgia accumulates reactive oxygen species
17 ia, outline the neuro-ophthalmic features of trigeminal neuralgia, and detail the neuro-ophthalmic si
18 r, as it is often confused with migraine and trigeminal neuralgia, and secondary causes may be overlo
19 e attacks with autonomic symptoms (SUNA) and trigeminal neuralgia are considered different disorders,
21 Percutaneous or open surgical procedures for trigeminal neuralgia can result in corneal anesthesia, n
22 Administration (FDA)-approved medication for trigeminal neuralgia carries substantial side effects, w
23 in oral medicine and found it effective for trigeminal neuralgia (category A) and probably effective
25 tematic review of surgical interventions for trigeminal neuralgia found not a single trial of what is
26 therapeutic overlap between SUNCT, SUNA, and trigeminal neuralgia has challenged this traditional vie
32 tment modalities available for patients with trigeminal neuralgia intolerable or resistant to medical
37 ffectiveness was strongest for SMRs used for trigeminal neuralgia, neck pain, and painful cramps; evi
38 radiosurgery for arteriovenous malformation, trigeminal neuralgia, or benign intracranial tumours, wh
39 the clinical manifestations and etiology of trigeminal neuralgia, outline the neuro-ophthalmic featu
40 toms in most patients with vessel-associated trigeminal neuralgia, probably because the resulting sep
41 ble patients aged 18-80 years with confirmed trigeminal neuralgia received open-label, BIIB074 150 mg
42 blems included peripheral visual field loss, trigeminal neuralgia, recurrent Bell's palsy, and pulsat
43 ological evidence on whether SUNCT, SUNA and trigeminal neuralgia should be considered separate entit
44 lockers indicates a therapeutic overlap with trigeminal neuralgia, suggesting that sodium channels dy
45 he past decade has offered new insights into trigeminal neuralgia symptomatology, pathophysiology, an
46 trigeminal nerve root (FLIT) model of human trigeminal neuralgia that has improved face, construct,
47 gated in a cohort of patients with classical trigeminal neuralgia, the prevalence and severity of neu
48 aetiological factor between SUNCT, SUNA and trigeminal neuralgia thereby further expanding the overl
54 clinically confirmed intractable unilateral trigeminal neuralgia were measured before treatment with
55 ession is a safe and effective treatment for trigeminal neuralgia, with a high rate of long-term succ
56 started on treatment with carbamazepine for trigeminal neuralgia, with modest improvement of symptom